医疗分销市场分析及预测（至2035年）：按类型、产品类型、服务、技术、组件、应用、最终用户和模式划分

预计医疗保健分销市场规模将从2024年的16亿美元成长到2034年的27亿美元，复合年增长率约为5.4%。医疗保健分销市场涵盖从药品、医疗设备和医疗产品製造商到医疗服务提供者的供应链管理。该市场强调品管、合规性和库存管理，以确保高效、及时地交付必要的医疗用品。医疗服务需求的成长和医疗技术的进步正在推动市场成长，同时，市场也更加重视整合数位化解决方案，以提高透明度和效率。

在技​​术进步和对高效供应链管理日益增长的需求驱动下，医疗保健分销市场持续发展。由于对及时送达药品和低温运输物流的需求不断增长，药品分销领域在业绩方面处于主导地位。在该领域中，高价值且处理要求复杂的特药表现尤为突出。紧随其后的是医疗设备分销领域，其中耗材和诊断设备是关键子领域。这些领域的成长主要得益于对预防保健和早期诊断的日益重视。数位化解决方案正越来越多地融入分销流程，从而提高透明度和效率。医疗产品电子商务平台正在成为一大趋势，提供便利性和广泛的覆盖范围。区块链和物联网领域的投资不断增加，用于优化供应链，确保可追溯性并降低假冒风险。总体而言，市场呈现成长态势，创新和技术在其中发挥关键作用。

医疗保健分销市场正经历市场份额、定价策略和产品创新方面的动态变化。产业领导者正利用策略联盟和技术创新来提高分销效率并扩展产品系列。新产品的推出反映了医疗服务提供者和患者不断变化的需求，尤其专注于专科药物和生物製药。定价策略的驱动力在于平衡成本效益和高品质服务交付的需求，这导致竞争加剧。这种格局为能够快速适应这些变化的公司提供了许多机会。医疗保健分销市场的竞争日益激烈，主要参与者正透过创新和策略收购争夺主导。监管的影响至关重要，它塑造着市场动态并制定合规标准。严格的法规确保了北美和欧洲的品质和安全，而新兴市场不断发展的法规结构则提供了成长机会。同侪标竿分析揭示了数位转型和供应链透明度提高的趋势。对技术整合和永续实践的关注正在推动市场成长。

主要趋势和驱动因素：

受数位医疗技术进步、全球人口老化以及慢性病日益增长的推动，医疗保健分销市场正经历显着增长。关键趋势包括将人工智慧 (AI) 和机器学习应用于供应链效率和准确性的提升。远端医疗和远端患者监护的兴起也在改变通路，需要更灵活高效的物流解决方案。推动该市场成长的因素还包括：需要一个高效的分销系统来满足不断增长的医疗保健服务和产品需求。个人化医疗和生物製药的扩展也影响分销策略，需要专业的处理和配送。此外，监管变化和对价值经销商进行创新并采用以患者为中心的模式。新兴市场医疗保健基础设施的快速发展带来了新的机会。能够提供扩充性且柔软性的分销解决方案的公司将占据有利地位，从而获得市场份额。此外，医疗保健产业正在进行的数位转型透过进阶分析和数据驱动的洞察开发，为成长提供了途径，从而实现更精准的库存管理和需求预测。医疗保健分销市场正在经历持续的变革，其驱动力来自技术进步和对高效医疗保健服务系统日益增长的需求。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

• 宏观经济分析
• 市场趋势
• 市场驱动因素
• 市场机会
• 市场限制
• 复合年均成长率：成长分析
• 影响分析
• 新兴市场
• 技术蓝图
• 战略框架

第四章 细分市场分析

• 市场规模及预测：依类型
  • 製药
  • 医疗设备
  • 生物技术产品
  • 营养补充品
  • 疫苗
  • 血液和血液製品
  • 诊断产品
• 市场规模及预测：依产品划分
  • 处方药
  • 非处方药
  • 学名药
  • 品牌药
  • 生物製药
  • 特种药品
  • 医疗设备
• 市场规模及预测：依服务划分
  • 后勤
  • 仓储
  • 库存管理
  • 订单履行
  • 低温运输解决方案
  • 运输
  • 附加价值服务
• 市场规模及预测：依技术划分
  • 自动化
  • 区块链
  • 物联网 (IoT)
  • 人工智慧
  • 云端运算
  • 机器人技术
  • 数据分析
• 市场规模及预测：依组件划分
  • 软体
  • 硬体
  • 服务
• 市场规模及预测：依应用领域划分
  • 医院药房
  • 零售药房
  • 网路药房
  • 诊所
  • 研究所
• 市场规模及预测：依最终用户划分
  • 医疗保健提供者
  • 製药公司
  • 研究所
  • 零售药房
  • 批发商
• 市场规模及预测：以交付形式划分
  • 直接分销
  • 间接分销

第五章 区域分析

• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲地区
• 亚太地区
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲
  • 台湾
  • 亚太其他地区
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 义大利
  • 其他欧洲地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非
  • 撒哈拉以南非洲
  • 其他中东和非洲地区

第六章 市场策略

• 需求与供给差距分析
• 贸易和物流限制
• 价格、成本和利润率趋势
• 市场渗透率
• 消费者分析
• 法规概述

第七章 竞争讯息

• 市场定位
• 市场占有率
• 竞争基准
• 主要企业的策略

第八章 公司简介

• Owens & Minor
• Henry Schein
• Cardinal Health
• Mc Kesson
• Amerisource Bergen
• Medline Industries
• Cencora
• Uniphar
• Phoenix Group
• Mawdsleys
• Alfresa Holdings
• Celesio
• Zuellig Pharma
• EBOS Group
• DKSH
• Orient Euro Pharma
• Meiji Seika Pharma
• Sinopharm
• Shanghai Pharmaceuticals
• Suzuken

第九章：关于我们

Healthcare Distribution Market is anticipated to expand from $1.6 billion in 2024 to $2.7 billion by 2034, growing at a CAGR of approximately 5.4%. The Healthcare Distribution Market encompasses the supply chain management of pharmaceuticals, medical devices, and healthcare products from manufacturers to healthcare providers. This market ensures the efficient and timely delivery of essential medical supplies, emphasizing quality control, regulatory compliance, and inventory management. Increasing demand for healthcare services and advancements in medical technology are propelling growth, with a focus on integrating digital solutions for enhanced transparency and efficiency.

The Healthcare Distribution Market is evolving, driven by technological advancements and increasing demand for efficient supply chain management. The pharmaceutical distribution segment leads in performance, propelled by the rising need for timely medication delivery and cold chain logistics. Within this segment, specialty drugs are the top performers due to their high value and complex handling requirements. The medical device distribution segment follows closely, with consumables and diagnostic equipment being key sub-segments. These are driven by the growing emphasis on preventive care and early diagnosis. The integration of digital solutions in distribution processes is gaining traction, enhancing transparency and efficiency. E-commerce platforms for healthcare products are emerging as a significant trend, offering convenience and wider reach. Investments in blockchain and IoT for supply chain optimization are increasing, ensuring traceability and reducing counterfeiting risks. Overall, the market is poised for growth, with innovation and technology playing pivotal roles.

The Healthcare Distribution Market is witnessing a dynamic shift in market share, pricing strategies, and product innovations. Industry leaders are leveraging strategic partnerships and technological advancements to enhance distribution efficiency and expand their portfolios. New product launches are characterized by a focus on specialty pharmaceuticals and biologics, reflecting the evolving demands of healthcare providers and patients. Pricing strategies are increasingly competitive, influenced by the need to balance cost efficiency with high-quality service delivery. This landscape is ripe with opportunities for companies that can adapt swiftly to these changes. Competition in the Healthcare Distribution Market is intensifying, with major players vying for dominance through innovation and strategic acquisitions. Regulatory influences play a pivotal role, shaping market dynamics and dictating compliance standards. In North America and Europe, stringent regulations ensure quality and safety, while emerging markets present opportunities for growth with evolving regulatory frameworks. Benchmarking against competitors reveals a trend towards digital transformation and enhanced supply chain transparency. The market is poised for growth, driven by technological integration and a focus on sustainable practices.

Geographical Overview:

The healthcare distribution market is witnessing dynamic growth across various regions, each with unique opportunities. North America maintains a dominant position due to advanced healthcare infrastructure and robust technological integration. The region's focus on improving healthcare delivery efficiency and expanding digital health solutions further propels market growth. Europe follows closely, driven by a strong regulatory framework and substantial investments in healthcare innovation. The region's emphasis on personalized medicine and sustainable healthcare practices enhances its market potential. In Asia Pacific, rapid economic development and increasing healthcare expenditures are fueling the market's expansion. Emerging markets like India and China are at the forefront, with significant investments in healthcare infrastructure. Latin America and the Middle East & Africa are emerging as promising growth pockets. In Latin America, rising demand for quality healthcare services and modernization of distribution channels contribute to market growth. Meanwhile, the Middle East & Africa are recognizing the importance of healthcare distribution in improving access to medical products and services.

The Healthcare Distribution Market is navigating complex global tariffs and geopolitical risks, significantly affecting supply chains in Japan, South Korea, China, and Taiwan. Japan and South Korea are enhancing their healthcare logistics capabilities to mitigate tariff impacts, while China is investing in domestic pharmaceutical distribution to counter trade barriers. Taiwan remains a pivotal player in medical device distribution but is susceptible to geopolitical tensions with China. The global market is robust, driven by technological advancements and increasing healthcare demands. By 2035, the market is expected to evolve with a focus on digitalization and regional collaborations. Middle East conflicts exert upward pressure on energy prices, indirectly affecting distribution costs and operational efficiencies across global supply chains, thereby influencing strategic decisions in these countries.

Key Trends and Drivers:

The healthcare distribution market is experiencing substantial growth, propelled by advancements in digital health technologies, an aging global population, and the increasing prevalence of chronic diseases. Key trends include the integration of artificial intelligence and machine learning, enhancing supply chain efficiency and accuracy. The rise of telemedicine and remote patient monitoring is also transforming distribution channels, necessitating more agile and responsive logistical solutions. Drivers of this market include the need for more efficient distribution systems to accommodate the growing demand for healthcare services and products. The expansion of personalized medicine and biologics is further influencing distribution strategies, requiring specialized handling and delivery. Additionally, regulatory changes and the emphasis on value-based care are pushing distributors to innovate and adopt more patient-centric approaches. Opportunities are emerging in emerging markets where healthcare infrastructure is rapidly developing. Companies that can provide scalable and flexible distribution solutions are well-positioned to capture market share. Moreover, the ongoing digital transformation in healthcare offers avenues for growth through the development of advanced analytics and data-driven insights, enabling better inventory management and demand forecasting. The healthcare distribution market is poised for continuous evolution, driven by technological advancements and the ever-increasing demand for efficient healthcare delivery systems.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Mode

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Pharmaceuticals
  • 4.1.2 Medical Devices
  • 4.1.3 Biotechnology Products
  • 4.1.4 Nutritional Supplements
  • 4.1.5 Vaccines
  • 4.1.6 Blood and Blood Products
  • 4.1.7 Diagnostic Products
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Prescription Drugs
  • 4.2.2 Over-the-Counter Drugs
  • 4.2.3 Generic Drugs
  • 4.2.4 Branded Drugs
  • 4.2.5 Biologics
  • 4.2.6 Specialty Pharmaceuticals
  • 4.2.7 Medical Equipment
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Logistics
  • 4.3.2 Warehousing
  • 4.3.3 Inventory Management
  • 4.3.4 Order Fulfillment
  • 4.3.5 Cold Chain Solutions
  • 4.3.6 Transportation
  • 4.3.7 Value-Added Services
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Automation
  • 4.4.2 Blockchain
  • 4.4.3 Internet of Things (IoT)
  • 4.4.4 Artificial Intelligence
  • 4.4.5 Cloud Computing
  • 4.4.6 Robotics
  • 4.4.7 Data Analytics
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Software
  • 4.5.2 Hardware
  • 4.5.3 Services
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Hospital Pharmacies
  • 4.6.2 Retail Pharmacies
  • 4.6.3 Online Pharmacies
  • 4.6.4 Clinics
  • 4.6.5 Research Institutes
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Healthcare Providers
  • 4.7.2 Pharmaceutical Companies
  • 4.7.3 Research Organizations
  • 4.7.4 Retail Pharmacies
  • 4.7.5 Wholesalers
• 4.8 Market Size & Forecast by Mode (2020-2035)
  • 4.8.1 Direct Distribution
  • 4.8.2 Indirect Distribution

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 End User
    • 5.2.1.8 Mode
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 End User
    • 5.2.2.8 Mode
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 End User
    • 5.2.3.8 Mode
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 End User
    • 5.3.1.8 Mode
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 End User
    • 5.3.2.8 Mode
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 End User
    • 5.3.3.8 Mode
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 End User
    • 5.4.1.8 Mode
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 End User
    • 5.4.2.8 Mode
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 End User
    • 5.4.3.8 Mode
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 End User
    • 5.4.4.8 Mode
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 End User
    • 5.4.5.8 Mode
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 End User
    • 5.4.6.8 Mode
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 End User
    • 5.4.7.8 Mode
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 End User
    • 5.5.1.8 Mode
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 End User
    • 5.5.2.8 Mode
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 End User
    • 5.5.3.8 Mode
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 End User
    • 5.5.4.8 Mode
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 End User
    • 5.5.5.8 Mode
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 End User
    • 5.5.6.8 Mode
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 End User
    • 5.6.1.8 Mode
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 End User
    • 5.6.2.8 Mode
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 End User
    • 5.6.3.8 Mode
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 End User
    • 5.6.4.8 Mode
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 End User
    • 5.6.5.8 Mode

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Owens & Minor
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Henry Schein
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Cardinal Health
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Mc Kesson
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Amerisource Bergen
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Medline Industries
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Cencora
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Uniphar
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Phoenix Group
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Mawdsleys
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Alfresa Holdings
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Celesio
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Zuellig Pharma
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 EBOS Group
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 DKSH
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Orient Euro Pharma
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Meiji Seika Pharma
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Sinopharm
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Shanghai Pharmaceuticals
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Suzuken
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us